Skip to main content

Table 3 Antibiotics susceptibility profile for selected Gram-negative bacteria as read in mean diameter of zones of inhibition (mm) after exposure to acoustic treatment at 1125 Hz/80 dB compared with control

From: Evaluation of the effects of sound exposure and low field electromagnetism on growth and antibiotics susceptibility of some microorganisms

Bacteria

Exposure

CAZ

CIP

TET

IMP

AMP

S. marcescens ATCC14756

a) Control

b) 24 h

c) 48 h

d) 72 h

26 ± 1.4

23 ± 1.4

23 ± 0

20 ± 9.2

28 ± 2.8

21 ± 1.4

29 ± 2.8

25 ± 0.7

R

R

R

12 ± 2.1

2.6 ± 1.4

29 ± 1.4

32 ± 1.4

26 ± 5.7

R

R

R

19 ± 4.2

P. aeruginosa

ATCC9027

a) Control

b) 24 h

c) 48 h

d) 72 h

a) 26 ± 1.4

b) 20 ± 9.2

c) 26 ± 2.1

d) 30 ± 0.7

a) 34 ± 3.5

b) 23 ± 3.5

c) 22 ± 0

d) 27 ± 1.4

a) R

b) R

c) 27 ± 2.8

d) R

a) 26 ± 2.8

b) 17 ± 4.2

c) R

d) 31 ± 4.9

a) R

b) R

c) R

d) R

G. oxydans

ATCC19357

a) Control

b) 24 h

c) 48 h

d) 72 h

a) 27 ± 2.8

b) 20 ± 0

c) 14 ± 2.1

d) R

a) 26 ± 0.7

b) 17 ± 2.1

c) 19 ± 1.4

d) 22 ± 0.7

a) R

b) R

c) 26 ± 2.8

d) R

a) 26 ± 1.4

b) 24 ± 3.5

c) R

d) 18 ± 13.4

a) 23 ± 0.7

b) R

c) 18 ± 0

d) R

R. sphaeroides

ATCC17023

a) Control

b) 24 h

c) 48 h

d) 72 h

a) 24 ± 0.7

b) 19 ± 0.7

c) 24 ± 1.4

d) 28 ± 0.7

a) 24 ± 0.7

b) 23 ± 0

c) 24 ± 3.5

d) 23 ± 3.5

a) R

b) R

c) 28 ± 0.7

d) R

a) R

b) 23 ± 3.5

c) R

d) 34 ± 0.7

a) R

b) R

c) R

d) R

C. freundii

ATCC33128

a) Control

b) 24 h

c) 48 h

d) 72 h

a) 14 ± 0.7

b) 14 ± 0

c) 20 ± 7.1

d) 30 ± 0

a) 26 ± 0.7

b) 24 ± 0.7

c) 31 ± 2.1

d) 30 ± 1.4

a) 25 ± 0

b) R

c) 12 ± 0.7

d) 11 ± 1.4

a) 29 ± 4.2

b) 25 ± 0.7

c) R

d) 30 ± 0

a) 30 ± 2.1

b) R

C) R

d) R

Y. pestis

ATCC11953

a) Control

b) 24 h

c) 48 h

d) 72 h

a) 13 ± 1.4

b) 23 ± 0.7

c) 18 ± 0

d) 16 ± 2.8

a) 23 ± 0

b) 22 ± 2.1

c) 20 ± 0.7

d) 18 ± 2.8

a) R

b) R

c) R

d) R

a) 23 ± 1.4

b) 20 ± 4.9

c) 26 ± 0.7

d) 23 ± 0.7

a) 15 ± 0

b) 14 ± 2.1

c) 15 ± 0.7

d) 17 ± 1.4

K. pneumoniae

ATCC25955

a) Control

b) 24 h

c) 48 h

d) 72 h

a) 26 ± 1.4

b) 27 ± 1.4

c) 26 ± 0.7

d) 26 ± 2.8

a) 31 ± 2.1

b) 21 ± 1.4

c) 23 ± 0.7

d) 25 ± 3.5

a) R

b) R

c) 25 ± 5.7

d) R

a) 22 ± 2.8

b) 30 ± 0.7

c) R

d) 31 ± 0.7

a) 24 ± 0.7

b) R

c) R

d) R

A.aceti

ATCC15973

a) Control

b) 24 h

c) 48 h

d) 72 h

a) 19 ± 4.2

b) 26 ± 0

c) 14 ± 4.2

d) 19 ± 0.7

a) 21 ± 9.9

b) 19 ± 2.1

c) 28 ± 4.9

d) 20 ± 0

a) 13 ± 4.2

b) R

c) 21 ± 14.1

d) 10 ± 0

a) 17 ± 1.4

b) 34 ± 7.1

c) 22 ± 2.8

d) 27 ± 1.4

a) 16 ± 4.2

b) 13 ± 1.4

c) R

d) R

E. coli

ATCC25922

a) Control

b) 24 h

c) 48 h

d) 72 h

a) 29 ± 1.4

b) 14 ± 1.4

c) 17 ± 0.7

d) 18 ± 1.4

a) 22 ± 1.4

b) 20 ± 0.7

c) 21 ± 1.4

d) 21 ± 0.7

a) 19 ± 0

b) R

c) 20 ± 4.2

d) R

a) 33 ± 4.2

b) 20 ± 0

c) R

d) 27 ± 1.4

a) 26 ± 1.4

b) R

c) R

d) R

  1. a) —Control b) —24 h c) —48 h d) —72 h R—Resistance CAZ—Ceftazidime CIP—Ciprofloxacin TET—Tetracycline IMP—Imipenem AMP—Ampicillin *Data are mean of replicate ± S.D